Hospital Acquired Infection Control Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Hospital-Acquired Infections Market Overview and the market is segmented by Product (Sterilant, Disinfectants, and Other Products), Indication (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections, and Other Indications), End User (Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Nursing Homes and Maternity Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Hospital Acquired Infection Control Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Hospital Acquired Infection Control Industry Overview

The hospital-acquired infection control market is highly competitive and consists of several players. Companies like 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux Sa, Cantel Medical, Ethicon, Getinge Group, Kimberly-Clark Corporation, Sterigenics International LLC, and Steris Corporation, among others, hold a substantial market share in the hospital-acquired infection control market.

Hospital Acquired Infection Control Market Leaders

  1. 3M Company

  2. Becton, Dickinson and Company

  3. Biomerieux SA

  4. Sterigenics International LLC

  5. Johnson and Johnson(Ethicon)

  6. *Disclaimer: Major Players sorted in no particular order
Hospital Acquired Infection Control Market Concentration